LivaNova PLC reported $1.47B of revenue over the trailing twelve months, +12% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.47B (to Q2 2026). Net income: $189M, trailing twelve months to Q2 2026. Free cash flow: $148M, trailing twelve months to Q2 2026. Operating margin: 13%, trailing twelve months to Q2 2026.

LIVNLivaNova PLC

Healthcare

$76.39+39% 1Y

$76.39

$49.5752 weeks$85.43

LIVN as reported

LivaNova PLC reported $1.47B of revenue over the trailing twelve months, +12% on the year before. 10 reported series are charted on this page, each one as filed.

$1.47B

Revenue, trailing twelve months · to Q2 2026 · +12% against the twelve months before

Net income: $189M
Net income · −189% year on year · trailing twelve months to Q2 2026
Free cash flow: $148M
Free cash flow · −8.5% year on year · trailing twelve months to Q2 2026
Operating margin: 13%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for LIVN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.47B	+12%	Q2 2026
Net income	$189M	−189%	Q2 2026
EPS	$3.38	−187%	Q2 2026
Gross margin	68%	n/a	Q2 2026
Operating margin	13%	n/a	Q2 2026
Net margin	13%	n/a	Q2 2026
ROE	−4.0%	n/a	Q2 2026
ROA	−1.6%	n/a	Q2 2026
ROIC	16%	n/a	Q2 2026
Free cash flow	$148M	−8.5%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.